Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas

Clinical trial condition

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas

Explore clinical trials studying Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas trial results

Completed

A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma

NCT02086175

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details